nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—SELE—epithelium—malignant mesothelioma	0.0546	0.0552	CbGeAlD
Carvedilol—VCAM1—epithelium—malignant mesothelioma	0.0502	0.0508	CbGeAlD
Carvedilol—HIF1A—epithelium—malignant mesothelioma	0.0483	0.0489	CbGeAlD
Carvedilol—VCAM1—decidua—malignant mesothelioma	0.0475	0.048	CbGeAlD
Carvedilol—GJA1—epithelium—malignant mesothelioma	0.0469	0.0474	CbGeAlD
Carvedilol—HIF1A—decidua—malignant mesothelioma	0.0457	0.0462	CbGeAlD
Carvedilol—GJA1—decidua—malignant mesothelioma	0.0443	0.0448	CbGeAlD
Carvedilol—NDUFC2—epithelium—malignant mesothelioma	0.0408	0.0413	CbGeAlD
Carvedilol—NDUFC2—decidua—malignant mesothelioma	0.0386	0.039	CbGeAlD
Carvedilol—VEGFA—decidua—malignant mesothelioma	0.035	0.0354	CbGeAlD
Carvedilol—SELE—lung—malignant mesothelioma	0.0347	0.0351	CbGeAlD
Carvedilol—SELE—testis—malignant mesothelioma	0.0327	0.0331	CbGeAlD
Carvedilol—VCAM1—lung—malignant mesothelioma	0.0319	0.0323	CbGeAlD
Carvedilol—HIF1A—lung—malignant mesothelioma	0.0307	0.0311	CbGeAlD
Carvedilol—VCAM1—testis—malignant mesothelioma	0.0301	0.0305	CbGeAlD
Carvedilol—GJA1—lung—malignant mesothelioma	0.0298	0.0301	CbGeAlD
Carvedilol—HIF1A—testis—malignant mesothelioma	0.029	0.0293	CbGeAlD
Carvedilol—GJA1—testis—malignant mesothelioma	0.0281	0.0284	CbGeAlD
Carvedilol—NDUFC2—lung—malignant mesothelioma	0.0259	0.0262	CbGeAlD
Carvedilol—NDUFC2—testis—malignant mesothelioma	0.0245	0.0247	CbGeAlD
Carvedilol—ADRA1D—epithelium—malignant mesothelioma	0.0242	0.0245	CbGeAlD
Carvedilol—VEGFA—lung—malignant mesothelioma	0.0235	0.0238	CbGeAlD
Carvedilol—VEGFA—testis—malignant mesothelioma	0.0222	0.0225	CbGeAlD
Carvedilol—ADRA1A—epithelium—malignant mesothelioma	0.0139	0.0141	CbGeAlD
Carvedilol—ADRA2C—decidua—malignant mesothelioma	0.0125	0.0126	CbGeAlD
Carvedilol—CYP1A1—epithelium—malignant mesothelioma	0.0113	0.0115	CbGeAlD
Carvedilol—ADRB1—lung—malignant mesothelioma	0.0112	0.0113	CbGeAlD
Carvedilol—ADRA2A—decidua—malignant mesothelioma	0.00998	0.0101	CbGeAlD
Carvedilol—PTGS1—epithelium—malignant mesothelioma	0.00996	0.0101	CbGeAlD
Carvedilol—ADRA2C—lung—malignant mesothelioma	0.00841	0.00851	CbGeAlD
Carvedilol—KCNH2—testis—malignant mesothelioma	0.00805	0.00814	CbGeAlD
Carvedilol—ADRA2C—testis—malignant mesothelioma	0.00794	0.00803	CbGeAlD
Carvedilol—CYP1A2—lung—malignant mesothelioma	0.0073	0.00738	CbGeAlD
Carvedilol—CYP1A1—lung—malignant mesothelioma	0.0072	0.00728	CbGeAlD
Carvedilol—ADRA2A—lung—malignant mesothelioma	0.00671	0.00679	CbGeAlD
Carvedilol—CYP2E1—lung—malignant mesothelioma	0.00657	0.00664	CbGeAlD
Carvedilol—ADRA2A—testis—malignant mesothelioma	0.00633	0.00641	CbGeAlD
Carvedilol—PTGS1—lung—malignant mesothelioma	0.00633	0.0064	CbGeAlD
Carvedilol—CYP2E1—testis—malignant mesothelioma	0.0062	0.00627	CbGeAlD
Carvedilol—PTGS1—testis—malignant mesothelioma	0.00597	0.00604	CbGeAlD
Carvedilol—ABCB1—epithelium—malignant mesothelioma	0.00589	0.00595	CbGeAlD
Carvedilol—ABCB1—decidua—malignant mesothelioma	0.00556	0.00562	CbGeAlD
Carvedilol—CYP2D6—testis—malignant mesothelioma	0.00491	0.00496	CbGeAlD
Carvedilol—ABCB1—lung—malignant mesothelioma	0.00374	0.00378	CbGeAlD
Carvedilol—ABCB1—testis—malignant mesothelioma	0.00353	0.00357	CbGeAlD
Carvedilol—SELE—Glucocorticoid receptor regulatory network—KRT5—malignant mesothelioma	0.00309	0.278	CbGpPWpGaD
Carvedilol—GJA1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—THBD—malignant mesothelioma	0.00199	0.179	CbGpPWpGaD
Carvedilol—SELE—Cell surface interactions at the vascular wall—THBD—malignant mesothelioma	0.0015	0.134	CbGpPWpGaD
Carvedilol—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—malignant mesothelioma	0.000423	0.038	CbGpPWpGaD
Carvedilol—SELE—Hemostasis—THBD—malignant mesothelioma	0.000406	0.0365	CbGpPWpGaD
Carvedilol—ADRB3—G alpha (s) signalling events—PTGER4—malignant mesothelioma	0.000248	0.0223	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—WT1—malignant mesothelioma	0.000212	0.019	CbGpPWpGaD
Carvedilol—ADRB1—G alpha (s) signalling events—PTGER4—malignant mesothelioma	0.000147	0.0132	CbGpPWpGaD
Carvedilol—ADRB2—G alpha (s) signalling events—PTGER4—malignant mesothelioma	0.000144	0.0129	CbGpPWpGaD
Carvedilol—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	0.000138	0.0124	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	0.000118	0.0106	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—THBD—malignant mesothelioma	0.000102	0.00919	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—PTGER4—malignant mesothelioma	9e-05	0.00808	CbGpPWpGaD
Carvedilol—ADRA1D—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	8.99e-05	0.00807	CbGpPWpGaD
Carvedilol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	8.19e-05	0.00735	CbGpPWpGaD
Carvedilol—ADRA2B—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	8.11e-05	0.00729	CbGpPWpGaD
Carvedilol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	8.01e-05	0.00719	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	7.7e-05	0.00692	CbGpPWpGaD
Carvedilol—ADRA2C—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	7.58e-05	0.00681	CbGpPWpGaD
Carvedilol—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	7.46e-05	0.0067	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	7.01e-05	0.0063	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	6.95e-05	0.00624	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	6.86e-05	0.00616	CbGpPWpGaD
Carvedilol—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	6.62e-05	0.00595	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant mesothelioma	6.54e-05	0.00587	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	6.49e-05	0.00583	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	6.39e-05	0.00574	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—PTGER4—malignant mesothelioma	6.31e-05	0.00567	CbGpPWpGaD
Carvedilol—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGER4—malignant mesothelioma	6.16e-05	0.00553	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—THBD—malignant mesothelioma	6.03e-05	0.00542	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—PTGER4—malignant mesothelioma	5.86e-05	0.00527	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	5.68e-05	0.0051	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—THBD—malignant mesothelioma	5.63e-05	0.00506	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—PTGER4—malignant mesothelioma	5.34e-05	0.0048	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—PTGER4—malignant mesothelioma	5.29e-05	0.00475	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—malignant mesothelioma	5.27e-05	0.00474	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—PTGER4—malignant mesothelioma	5.23e-05	0.00469	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—PTGER4—malignant mesothelioma	5.09e-05	0.00457	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—PTGER4—malignant mesothelioma	4.94e-05	0.00444	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—PTGER4—malignant mesothelioma	4.87e-05	0.00437	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—PTGER4—malignant mesothelioma	4.62e-05	0.00415	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—THBD—malignant mesothelioma	4.58e-05	0.00411	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—PTGER4—malignant mesothelioma	4.32e-05	0.00388	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—PTGER4—malignant mesothelioma	4.02e-05	0.00361	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—PTGER4—malignant mesothelioma	3.31e-05	0.00298	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—PTGER4—malignant mesothelioma	3.02e-05	0.00271	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—PTGER4—malignant mesothelioma	3.01e-05	0.0027	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—PTGER4—malignant mesothelioma	2.99e-05	0.00269	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—PTGER4—malignant mesothelioma	2.95e-05	0.00265	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—PTGER4—malignant mesothelioma	2.79e-05	0.00251	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—PTGER4—malignant mesothelioma	2.75e-05	0.00247	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—PTGER4—malignant mesothelioma	2.74e-05	0.00246	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PTGER4—malignant mesothelioma	2.73e-05	0.00245	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PTGER4—malignant mesothelioma	2.72e-05	0.00245	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—PTGER4—malignant mesothelioma	2.72e-05	0.00244	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—PTGER4—malignant mesothelioma	2.68e-05	0.00241	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—PTGER4—malignant mesothelioma	2.54e-05	0.00228	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—PTGER4—malignant mesothelioma	2.5e-05	0.00224	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—PTGER4—malignant mesothelioma	2.44e-05	0.00219	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—PTGER4—malignant mesothelioma	2.27e-05	0.00204	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—PTGER4—malignant mesothelioma	2.22e-05	0.00199	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—PTGER4—malignant mesothelioma	2.06e-05	0.00185	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTGER4—malignant mesothelioma	1.78e-05	0.0016	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTGER4—malignant mesothelioma	1.62e-05	0.00145	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTGER4—malignant mesothelioma	1.6e-05	0.00144	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTGER4—malignant mesothelioma	1.58e-05	0.00142	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTGER4—malignant mesothelioma	1.5e-05	0.00135	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTGER4—malignant mesothelioma	1.48e-05	0.00132	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTGER4—malignant mesothelioma	1.31e-05	0.00118	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTGER4—malignant mesothelioma	1.22e-05	0.00109	CbGpPWpGaD
